These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38809316)

  • 1. Shenqi Fuzheng injection hinders non-small cell lung cancer cell growth by regulating the Bax/Bcl-2 signaling pathway.
    Li S; Ma T; Li G; Cheng X; Wen T; Wang Y; Zhang H; Liu Z
    Discov Oncol; 2024 May; 15(1):195. PubMed ID: 38809316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway.
    Wang J; He X; Jia Z; Yan A; Xiao K; Liu S; Hou M; Long Y; Ding X
    Pharm Biol; 2024 Dec; 62(1):33-41. PubMed ID: 38100532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology-based investigation of the effects of Shenqi Fuzheng injection on glioma proliferation and migration via the SRC/PI3K/AKT signaling pathway.
    Li S; Zhu Z; Chen Z; Guo Z; Wang Y; Li X; Ma K
    J Ethnopharmacol; 2024 Jun; 328():118128. PubMed ID: 38561056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells.
    Pan Z; Wang K; Chen Q; Zheng X; Song Z; Ding X
    J Cancer; 2020; 11(2):334-344. PubMed ID: 31897229
    [No Abstract]   [Full Text] [Related]  

  • 5. Shenqi Fuzheng Injection Reverses Cisplatin Resistance through Mitofusin-2-Mediated Cell Cycle Arrest and Apoptosis in A549/DDP Cells.
    Xiong Y; Zhao Q; Gu L; Liu C; Wang C
    Evid Based Complement Alternat Med; 2018; 2018():8258246. PubMed ID: 30410558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shenqi Fuzheng injection modulates tumor fatty acid metabolism to downregulate MDSCs infiltration, enhancing PD-L1 antibody inhibition of intracranial growth in Melanoma.
    Ma Y; Qi Y; Zhou Z; Yan Y; Chang J; Zhu X; Han J; Wu H; Tao Y; Fan F
    Phytomedicine; 2024 Jan; 122():155171. PubMed ID: 37925891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shenqi Fuzheng injection facilitates skeletal muscle mitophagy mediated by the ubiquitination of HIF-1α to ameliorate cancer-associated fatigue.
    Guo W; Liu S; Xia H; Luo J; Chen H; Hu L; Zheng X; Xiao Z; Lin L
    J Cell Mol Med; 2024 Jun; 28(12):e18455. PubMed ID: 38898772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review.
    Dong J; Su SY; Wang MY; Zhan Z
    J Exp Clin Cancer Res; 2010 Oct; 29(1):137. PubMed ID: 20969765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systematic review and Meta-analysis of Shenqi Fuzheng injection combined with first-line chemotherapy for non-small cell lung cancer].
    Hao TT; Xie YM; Liao X; Wang J
    Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(20):4094-107. PubMed ID: 27062833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of EGFR‑TKIs plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations.
    Wang JL; Chen CS; Jia ZR; Miao LY; Xie J; Pan ZZ; Duan YL; Liu S; Hou MJ; Ding XS
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3895-3903. PubMed ID: 36008690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ShenQi FuZheng Injection ameliorates fatigue-like behavior in mouse models of cancer-related fatigue.
    Zhu G; Zhang B; Jiang F; Zhao L; Liu F
    Biomed Pharmacother; 2019 Mar; 111():1376-1382. PubMed ID: 30841452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RPB5-mediating protein promotes the progression of non-small cell lung cancer by regulating the proliferation and invasion.
    Feng Y; Chen K; Pan L; Jiang W; Pang P; Mao G; Zhang B; Chen S
    J Thorac Dis; 2021 Jan; 13(1):299-311. PubMed ID: 33569210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway.
    Yu Q; Lan T; Ma Z; Wang Z; Zhang C; Jiang Y; Zhao Z
    Transl Androl Urol; 2023 Aug; 12(8):1296-1307. PubMed ID: 37680227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway.
    Wu Y; Liu C; Niu Y; Xia J; Fan L; Wu Y; Gao W
    Transl Cancer Res; 2021 May; 10(5):2023-2035. PubMed ID: 35116524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Shenqi Fuzheng injection combined with chemotherapy for cancer: An overview of systematic reviews.
    Chen G; Lu J; Li B; Zhao M; Liu D; Yang Z; Liu F
    Phytomedicine; 2024 Mar; 125():155293. PubMed ID: 38295658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
    Li XY; Ma K; Yan JN; You FC; Ma L
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 19-Hydroxybufalin inhibits non-small cell lung cancer cell proliferation and promotes cell apoptosis via the Wnt/β-catenin pathway.
    Yu W; Zhang X; Zhang W; Xiong M; Lin Y; Chang M; Xu L; Lu Y; Liu Y; Zhang J
    Exp Hematol Oncol; 2021 Oct; 10(1):48. PubMed ID: 34696818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xiaoai Jiedu Recipe Inhibits Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells by Blocking the P38 Mitogen-Activated Protein Kinase (MAPK) Pathway.
    Wang Y; Xu C; Xu B; Li L; Li W; Wang W; Wu M
    Med Sci Monit; 2019 Oct; 25():7538-7546. PubMed ID: 31590176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.